Alivus acquires 9.21% in renewable-energy SPV for Rs. 14.04 crore
As filed · Alivus Life Sciences Limited has informed the Exchange about announcement under Regulation 30 of SEBI (LODR), 2015 - Acquisition.
M&AImprovingLowmateriality 42 out of 100
What happened
FactAlivus Life Sciences acquired a 9.21% equity stake in Torrent Urja 19 Private Limited for Rs. 14.04 crores in cash. The investment is intended to support renewable-power use and qualify Alivus as a captive user under the Electricity Act, 2003.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
Scale
- 0.6% of FY26 revenue
₹14.04 Cr stated in the filing against ₹2,551.83 Cr revenue (FY26, standalone)
Source: financial_facts · exchange_table
Watch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- Going forward, we continue to expect high single-digit revenue growth for FY’26, driven by strong and profitab (management committed by FY26)
- In about 1 to 1.5 years, we can get the project going. (management committed by H1 FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- The transaction provides Alivus exposure to renewable-power generation and is designed to meet captive-user requirements. It also supports the company's stated commitment to become carbon neutral by 2030.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%